Evidence map›Paper›PMID 29573211›Full record

ArticleMolecular oral microbiology2018

Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes.

R P Settem, K Honma, M Shankar, M Li, M LaMonte, D Xu, R J Genco, R W Browne, A Sharma

Open access · greenAbstract read
In one paragraph

Article in Molecular oral microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Persistence ofCurrent oral health reports · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

R P SettemDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0002-3577-7675
K HonmaDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
M ShankarDepartment of Biotechnical and Clinical Laboratory Sciences, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
M LiDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
M LaMonteDepartment of Epidemiology and Environmental Health, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
D XuDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
R J GencoDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
R W BrowneDepartment of Biotechnical and Clinical Laboratory Sciences, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.
A SharmaDepartment of Oral Biology, School of Public Health and Health Related Professions, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0001-9252-0668
University at Buffalo, State University of New York · US

Funding

T. forsythia TLR2 ligands and surface glycans coordinate periodontal inflammationR01DE014749 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SHARMA, ASHU · 2003 to 2018
$4.9M
Advanced Training in Oral BiologyT32DE023526 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Stefan Hans-Klaus Ruhl · 2013 to 2026
$3.7M
Heparan Sulfate–Osteoprotegerin Interactions in Bone RemodelingR01AR070179 · NIAMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI XU, DING · 2017 to 2021
$1.7M
NIAMS NIH HHS R01 AR070179NIDCR NIH HHS R01 DE014749NIDCR NIH HHS T32 DE023526
6 · The paper itself

Abstract

The periodontal pathogen Tannerella forsythia has the unique ability to produce methylglyoxal (MGO), an electrophilic compound which can covalently modify amino acid side chains and generate inflammatory adducts known as advanced glycation endproducts (AGEs). In periodontitis, concentrations of MGO in gingival-crevicular fluid are increased and are correlated with the T. forsythia load. However, the source of MGO and the extent to which MGO may contribute to periodontal inflammation has not been fully explored. In this study we identified a functional homolog of the enzyme methylglyoxal synthase (MgsA) involved in the production of MGO in T. forsythia. While wild-type T.forsythia produced a significant amount of MGO in the medium, a mutant lacking this homolog produced little to no MGO. Furthermore, compared with the spent medium of the T. forsythia parental strain, the spent medium of the T. forsythia mgsA-deletion strain induced significantly lower nuclear factor-kappa B activity as well as proinflammogenic and pro-osteoclastogenic cytokines from THP-1 monocytes. The ability of T. forsythia to induce protein glycation endproducts via MGO was confirmed by an electrophoresis-based collagen chain mobility shift assay. Together these data demonstrated that T. forsythia produces MGO, which may contribute to inflammation via the generation of AGEs and thus act as a potential virulence factor of the bacterium.

Indexed as

CytokinesGlycation End Products, AdvancedHumansInflammationMonocytesPeriodontitisPyruvaldehydeTannerella forsythiaTHP-1 CellsVirulence FactorsCytokinesGlycation End Products, AdvancedPyruvaldehydeVirulence FactorsAGEsmethylglyoxalperiodontitisRAGETannerella forsythia

Identifiers

PMID29573211
PMCPMC6041129
OpenAlexW2791664869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.